To access this element change to forms mode OFF

Grant Award View - GA279507

The Development of splice-switching oligonucleotides for the management...

Contact Details

NHMRC Research Help Centre

:
1800500393

:

GA ID:
GA279507
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
27-Oct-2022
Publish Date:
23-Jan-2023
Category:
Medical Research
Grant Term:
1-Jan-2023 to 31-Dec-2025
Value (AUD):
$907,815.46 (GST inclusive where applicable)

One-off/Ad hoc:
No
Aggregate Grant Award:
No

PBS Program Name:
NHMRC 21/22 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
The Development of splice-switching oligonucleotides for the management of kidney disease
Purpose:
.
RNA can now be used to treat human diseases.

It can be used as a template to make a new protein, such as in mRNA vaccines.

But RNA can also be used change how coding elements are spliced together and the protein that results from them.

This strategy has been used to great effect in difficult-to-treat diseases like muscular dystrophy and spinomuscular atrophy.

We will apply this same technology to target pathways critically involved in the development and progression of chronic kidney disease.


GO ID:
GO Title:
Ideas Grants 2022
Internal Reference ID:
2022/GNT2021732
Selection Process:
Targeted or Restricted Competitive

Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property

Grant Recipient Details

Recipient Name:
Monash University
Recipient ABN:
12 377 614 012

Grant Recipient Location

Suburb:
Clayton
Town/City:
Clayton
Postcode:
3800
State/Territory:
VIC
Country:
AUSTRALIA

Grant Delivery Location

State/Territory:
ACT, VIC, WA
Postcode:
Multiple
Country:
AUSTRALIA

Contact Details

NHMRC Research Help Centre

:
1800500393

: